Platelet genomics and the risk of atherothrombosis

Journal of Thrombosis and Haemostasis

Volumn 5, Issue SUPPL. 1, 2007, Pages 188-195

  Ouwehand, Willem H ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Genome scans; Platelets; Systems biology

Indexed keywords

ADENOSINE DIPHOSPHATE; BETA1 INTEGRIN; DNA; GLYCOPROTEIN IB ALPHA; GLYCOPROTEIN IIIA; PURINE P2Y12 RECEPTOR;

AMINO ACID SEQUENCE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; COHORT ANALYSIS; CORONARY ARTERY; DNA DETERMINATION; GENE EXPRESSION; GENE FREQUENCY; GENETIC RISK; GENOMICS; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HEART INFARCTION; HUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN MICROARRAY; PROTEOMICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RISK ASSESSMENT; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMS BIOLOGY; THROMBOCYTE; THROMBOCYTE FUNCTION; THROMBOSIS;

EID: 34250719345     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2007.02550.x     Document Type: Review

References (60)

1. Lander ES, Linton LM, Birren B, et al. Initial sequencing and analysis of the human genome. Nature 2001; 409: 860-921.
2. Cheng J, Kapranov P, Drenkow J, et al. Transcriptional maps of 10 human chromosomes at 5-nucleotide resolution. Science 2005; 308: 1149-54.
3. Kruglyak L, Nickerson DA. Variation is the spice of life. Nat Genet 2001; 27: 234-6.
4. dbSNP database at the National Center for Biotechnology Information (NCBI). http://www.ncbi.nlm.nih.gov/projects/SNP.
5. Sachidanandam R, Weissman D, Schmidt SC, et al. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature 2001; 409: 928-33.
6. The International HapMap Consortium. The International HapMap Project. Nature 2003; 426: 789-96.
7. The International HapMap Consortium. A haplotype map of the human genome. Nature 2005; 437: 1299-320.
8. Barrett JC, Cardon LR. Evaluating coverage of genome-wide association studies. Nat Genet 2006; 38: 659-62.
9. Anstee D, Klein H. Mollison's Blood Transfusion in Clinical Medicine: (11th edn) Blackwell Publishing, 2005.
10. Redon R, Ishikawa S, Fitch KR, et al. Global variation in copy number in the human genome. Nature 2006; 444: 444-54.
11. Pray L. A cheap personal genome. Genome Biol. 2002.
12. Feldman MW, Otto SP. Twin studies, heritability, and intelligence. Science 1997; 278: 1383-4.
13. Zdravkovic S, Wienke A, Pedersen NL, Marenberg ME, Yashin AI, De Faire U. Heritability of death from coronary heart disease: A 36-year follow-up of 20 966 Swedish twins. J Intern Med 2002; 252: 247-54.
14. Wang WY, Barratt BJ, Clayton DG, Todd JA. Genome-wide association studies: Theoretical and practical concerns. Nat Rev Genet 2005; 6: 109-18.
15. Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 2003; 33: 177-82.
16. Zondervan KT, Cardon LR. The complex interplay among factors that influence allelic association. Nat Rev Genet 2004; 5: 89-100.
17. Macaulay IC, Tijssen MR, Thijssen-Timmer DC, et al. Comparative gene expression profiling of in vitro differentiated megakaryocytes and erythroblasts identifies novel activatory and inhibitory platelet membrane proteins. Blood 2006; 109: 3260-9.
18. Macaulay IC, Carr P, Gusnanto A, Ouwehand WH, Fitzgerald D, Watkins NA. Platelet genomics and proteomics in human health and disease. J Clin Invest 2005; 115: 3370-7.
19. Macaulay IC, Carr P, Farrugia R, Watkins NA. Analysing the platelet transcriptome. Vox Sang 2004; 87(Suppl 2): 42-6.
20. Newland SA, Macaulay IC, Floto RA, et al. The novel inhibitory receptor G6B is expressed on the surface of platelets and attenuates platelet function in vitro. Blood 2007; Epub ahead of print.
21. Ye Z, Liu EH, Higgins JP, et al. Seven haemostatic gene polymorphisms in coronary disease: Meta-analysis of 66,155 cases and 91,307 controls. Lancet 2006; 367: 651-8.
22. Meisel C, Lopez JA, Stangl K. Role of platelet glycoprotein polymorphisms in cardiovascular diseases. Naunyn Schmiedebergs Arch Pharmacol 2004; 369: 38-54.
23. Metcalfe P, Watkins NA, Ouwehand WH, et al. Nomenclature of human platelet antigens. Vox Sang 2003; 85: 240-5.
24. Aleksic N, Juneja H, Folsom AR, et al. Platelet Pl(A2) allele and incidence of coronary heart disease: Results from the Atherosclerosis Risk In Communities (ARIC) Study. Circulation 2000; 102: 1901-5.
25. Bottiger C, Kastrati A, Koch W, et al. HPA-1 and HPA-3 polymorphisms of the platelet fibrinogen receptor and coronary artery disease and myocardial infarction. Thromb Haemost 2000; 83: 559-62.
26. Streifler JY, Rosenberg N, Chetrit A, et al. Cerebrovascular events in patients with significant stenosis of the carotid artery are associated with hyperhomocysteinemia and platelet antigen-1 (Leu33Pro) polymorphism. Stroke 2001; 32: 2753-8.
27. Kuijpers RW, Ouwehand WH, Bleeker PM, Christie D, Von dem Borne AE. Localization of the platelet-specific HPA-2 (Ko) alloantigens on the N-terminal globular fragment of platelet glycoprotein Ib alpha. Blood 1992; 79: 283-8.
28. Mikkelsson J, Perola M, Penttila A, Karhunen PJ. Platelet glycoprotein Ibalpha HPA-2 Met/VNTR B haplotype as a genetic predictor of myocardial infarction and sudden cardiac death. Circulation 2001; 104: 876-80.
29. Weiss EJ, Bray PF, Tayback M, et al. A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. N Engl J Med 1996; 334: 1090-4.
30. Immune polymorphism database at the European Bioinformatics Institute. wwwebiacuk/ipd/hpa. 2003.
31. Baker RI, Eikelboom J, Lofthouse E, et al. Platelet glycoprotein Ibalpha Kozak polymorphism is associated with an increased risk of ischemic stroke. Blood 2001; 98: 36-40.
32. Moshfegh K, Wuillemin WA, Redondo M, et al. Association of two silent polymorphisms of platelet glycoprotein Ia/IIa receptor with risk of myocardial infarction: A case-control study. Lancet 1999; 353: 351-4.
33. Santoso S, Kunicki TJ, Kroll H, Haberbosch W, Gardemann A. Association of the platelet glycoprotein Ia C807T gene polymorphism with nonfatal myocardial infarction in younger patients. Blood 1999; 93: 2449-53.
34. Von Beckerath N, Koch W, Mehilli J, Bottiger C, Schomig A, Kastrati A. Glycoprotein Ia gene C807T polymorphism and risk for major adverse cardiac events within the first 30 days after coronary artery stenting. Blood 2000; 95: 3297-301.
35. Goodall AH, Curzen N, Panesar M, et al. Increased binding of fibrinogen to glycoprotein IIIa-proline33 (HPA-1b, PlA2, Zwb) positive platelets in patients with cardiovascular disease. Eur Heart J 1999; 20: 742-7.
36. Zimrin AB, Gidwitz S, Lord S, et al. The genomic organization of platelet glycoprotein IIIa. J Biol Chem 1990; 265: 8590-5.
37. Watkins NA, O'Connor MN, Rankin A, et al. Definition of novel GP6 polymorphisms and major difference in haplotype frequencies between populations by a combination of in-depth exon resequencing and genotyping with tag single nucleotide polymorphisms. J Thromb Haemost 2006; 4: 1197-205.
38. Croft SA, Samani NJ, Teare MD, et al. Novel platelet membrane glycoprotein VI dimorphism is a risk factor for myocardial infarction. Circulation 2001; 104: 1459-63.
39. Knight CG, Morton LF, Onley DJ, et al. Collagen-platelet interaction: Gly-Pro-Hyp is uniquely specific for platelet Gp VI and mediates platelet activation by collagen. Cardiovasc Res 1999; 41: 450-7.
40. Joutsi-Korhonen L, Smethurst PA, Rankin A, et al. The low-frequency allele of the platelet collagen signaling receptor glycoprotein VI is associated with reduced functional responses and expression. Blood 2003; 101: 4372-9.
41. Clemetson JM, Polgar J, Magnenat E, Wells TN, Clemetson KJ. The platelet collagen receptor glycoprotein VI is a member of the immunoglobulin superfamily closely related to FcalphaR and the natural killer receptors. J Biol Chem 1999; 274: 29019-24.
42. Martin AM, Kulski JK, Witt C, Pontarotti P, Christiansen FT. Leukocyte Ig-like receptor complex (LRC) in mice and men. Trends Immunol 2002; 23: 81-8.
43. Zahn A, Jennings N, Ouwehand WH, Allain JP. Hepatitis C virus interacts with human platelet glycoprotein VI. J Gen Virol 2006; 87: 2243-51.
44. Todd JA. Statistical false positive or true disease pathway? Nat Genet 2006; 38: 731-3.
45. Rosendaal FR, Reitsma PH. Genetic studies in complex disease. J Thromb Haemost 2004; 2: 342.
46. Marchini J, Cardon LR, Phillips MS, Donnelly P. The effects of human population structure on large genetic association studies. Nat Genet 2004; 36: 512-7.
47. Clayton DG, Walker NM, Smyth DJ, et al. Population structure, differential bias and genomic control in a large-scale, case-control association study. Nat Genet 2005; 37: 1243-6.
48. Stranger BE, Forrest MS, Dunning M, et al. Relative impact of nucleotide and copy number variation on gene expression phenotypes. Science 2007; 315: 848-53.
49. Gnatenko DV, Dunn JJ, McCorkle SR, Weissmann D, Perrotta PL, Bahou WF. Transcript profiling of human platelets using microarray and serial analysis of gene expression. Blood 2003; 101: 2285-93.
50. Coppinger JA, Cagney G, Toomey S, et al. Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions. Blood 2004; 103: 2096-104.
51. Watson SP, Bahou WF, Fitzgerald D, Ouwehand W, Rao AK, Leavitt AD. Mapping the platelet proteome: A report of the ISTH Platelet Physiology Subcommittee. J Thromb Haemost 2005; 3: 2098-101.
52. Power C, Elliott J. Cohort profile: 1958 British birth cohort (National Child Development Study). Int J Epidemiol 2006; 35: 34-41.
53. Sladek R, Rocheleau G, Rung J, et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 2007; 445: 881-5.
54. Gilchrist M, Thorsson V, Li B, et al. Systems biology approaches identify ATF3 as a negative regulator of Toll-like receptor 4. Nature 2006; 441: 173-8.
55. Gold B, Merriam JE, Zernant J, et al. Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat Genet 2006; 38: 458-62.
56. Haines JL, Hauser MA, Schmidt S, et al. Complement factor H variant increases the risk of age-related macular degeneration. Science 2005; 308: 419-21.
57. Klein RJ, Zeiss C, Chew EY, et al. Complement factor H polymorphism in age-related macular degeneration. Science 2005; 308: 385-9.
58. Li M, Atmaca-Sonmez P, Othman M, et al. CFH haplotypes without the Y402H coding variant show strong association with susceptibility to age-related macular degeneration. Nat Genet 2006; 38: 1049-54.
59. Marx J. Genetics. A clearer view of macular degeneration. Science 2006; 311: 1704-5.
60. O'Rahilly S, Wareham NJ. Genetic variants and common diseases-better late than never. N Engl J Med 2006; 355: 306-8.